Stay updated on TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s software/display revision indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change rather than an update to the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-25T17:37:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:07:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:53:20.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3; the previous Revision: v3.4.2 label is no longer displayed.
    Difference
    0.1%
    Check dated 2026-03-06T19:01:54.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 from the Study Documents section.
    Difference
    0.1%
    Check dated 2026-02-13T12:37:01.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The changes show a minor revision label update, adding Revision: v3.4.1 and removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:24:36.000Z thumbnail image

Stay in the know with updates to TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.